Metformin in Combined With Cisplatin Plus Paclitaxel With Advanced Esophageal Squamous Cell Carcinoma (ECMTPneo)
Status:
Unknown status
Trial end date:
2020-06-20
Target enrollment:
Participant gender:
Summary
This is an open-label phase II trial investigating the effect of metformin in combined with
cisplatin plus paclitaxel as neoadjuvant therapy with advanced esophageal squamous cell
carcinoma.